Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review

Detalhes bibliográficos
Autor(a) principal: Silva, Lílian Pereira e
Data de Publicação: 2021
Outros Autores: Bezerra, Keila Cristiane Batista, Landim, Liejy Agnes dos Santos Raposo
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/22051
Resumo: The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in     patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality.
id UNIFEI_c6635ce2691c5d41b25da9c44fa76295
oai_identifier_str oai:ojs.pkp.sfu.ca:article/22051
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a reviewEvidencia científica sobre el esteviósido en el control de la Diabetes mellitus tipo 2: una revisiónEvidências científicas acerca do esteviosídeo no controle do Diabetes mellitus tipo 2: uma revisão Diabetes mellitus type IISteviaSteviosídeGlycosides.Diabetes mellitus tipo2SteviaEsteviósidoGlucósidos.EstéviaEsteviosídeoDiabetes mellitus tipo 2Glicosídeos.The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in     patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality.El objetivo de este estudio fue buscar evidencia científica para evaluar el uso y la acción del esteviósido en pacientes con diabetes mellitus tipo 2. Esta es una revisión de literatura integradora, las fuentes de búsqueda se encontraban en las siguientes bases de datos: (Scielo), (PubMed), LILACS y Academic Google. Para la selección de la muestra se establecieron criterios para artículos originales indexados de 2017 a 2021. La elección de este período cumplió con el criterio de temporalidad, en el que se consideró el corte quinquenal, por tratarse de publicaciones más actuales, en inglés y portugués. En los estudios examinados, se evidenció que el esteviósido es un compuesto glucosídico con alto dulzor, bajo valor calórico, incluyendo la interacción con glimeripedina y metformina, que potencia la reducción glucémica mediante acciones antioxidantes y mejora el perfil lipídico. Su acción también se destaca en la reducción de los niveles de glucosa y colesterol total, previniendo el daño oxidativo y mejorando la función hepática y renal, además de reducir el daño a los órganos internos al eliminar el colágeno tisular y contribuir al funcionamiento cardíaco normal. También demuestra resultados positivos en saciedad, contribuyendo a un retraso en el vaciamiento gástrico y siendo útil en el tratamiento de la obesidad, actuando en la inhibición de la absorción de glucosa. Así, se concluye que el esteviósido tiene acción preventiva y metabólica, además de promover estudios preclínicos y experimentales, culminando en efectos no calóricos, antidiabéticos y antihiperglucémicos, con calidad sensorial, terapéutica y nutricional.O objetivo desse estudo foi fazer uma busca de evidências científicas para avaliar o uso e ação do esteviosídeo em pacientes com diabetes mellitus tipo2. Trata-se de uma de revisão integrativa da literatura, as fontes de busca foram às bases de dados: Scielo, PubMed, LILACS e Google Acadêmico. Para a seleção da amostra foi estabelecido critérios de artigos originais indexados de 2017 a 2021, a escolha deste período atendeu ao critério de temporalidade, em que foi considerado o recorte de cinco anos, por se tratar de publicações mais atuais, na língua inglesa e portuguesa. Nos estudos examinados evidenciou-se que o esteviosídeo se apresenta como um composto glicosídico com elevada doçura, baixo valor calórico, inclui a interação à glimeripedina e metformina, o que potencializa a redução glicêmica por meio de ações antioxidantes e melhora do perfil lipídico. Ressalta-se ainda sua ação na diminuição dos níveis de glicose e colesterol total, prevenção do dano oxidativo e melhora da função hepática e renal, como também reduz os danos dos órgãos internos fazendo a remoção tecidual de colágeno e contribuindo para o funcionamento normal cardíaco.  Também demonstra resultados positivos na saciedade contribuindo para retardo do esvaziamento gástrico e sendo útil no tratamento da obesidade atuando na inibição da absorção de glicose. Dessa forma, conclui-se que o esteviosídeo tem ação preventiva e metabólica, além de fomentar estudos pré-clínicos e experimentais, culminando em efeitos não calóricos, antidiabéticos e anti-hiperglicêmicos, apresentando qualidade sensorial, terapêutica e nutricional.Research, Society and Development2021-11-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2205110.33448/rsd-v10i14.22051Research, Society and Development; Vol. 10 No. 14; e331101422051Research, Society and Development; Vol. 10 Núm. 14; e331101422051Research, Society and Development; v. 10 n. 14; e3311014220512525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22051/19732Copyright (c) 2021 Lílian Pereira e Silva; Keila Cristiane Batista Bezerra; Liejy Agnes dos Santos Raposo Landimhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Lílian Pereira e Bezerra, Keila Cristiane Batista Landim, Liejy Agnes dos Santos Raposo 2021-12-04T11:48:39Zoai:ojs.pkp.sfu.ca:article/22051Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:19.270786Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
Evidencia científica sobre el esteviósido en el control de la Diabetes mellitus tipo 2: una revisión
Evidências científicas acerca do esteviosídeo no controle do Diabetes mellitus tipo 2: uma revisão
title Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
spellingShingle Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
Silva, Lílian Pereira e
Diabetes mellitus type II
Stevia
Steviosíde
Glycosides.
Diabetes mellitus tipo2
Stevia
Esteviósido
Glucósidos.
Estévia
Esteviosídeo
Diabetes mellitus tipo 2
Glicosídeos.
title_short Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
title_full Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
title_fullStr Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
title_full_unstemmed Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
title_sort Scientific evidences about this steviosíde in mellitus Diabetes type 2 control: a review
author Silva, Lílian Pereira e
author_facet Silva, Lílian Pereira e
Bezerra, Keila Cristiane Batista
Landim, Liejy Agnes dos Santos Raposo
author_role author
author2 Bezerra, Keila Cristiane Batista
Landim, Liejy Agnes dos Santos Raposo
author2_role author
author
dc.contributor.author.fl_str_mv Silva, Lílian Pereira e
Bezerra, Keila Cristiane Batista
Landim, Liejy Agnes dos Santos Raposo
dc.subject.por.fl_str_mv Diabetes mellitus type II
Stevia
Steviosíde
Glycosides.
Diabetes mellitus tipo2
Stevia
Esteviósido
Glucósidos.
Estévia
Esteviosídeo
Diabetes mellitus tipo 2
Glicosídeos.
topic Diabetes mellitus type II
Stevia
Steviosíde
Glycosides.
Diabetes mellitus tipo2
Stevia
Esteviósido
Glucósidos.
Estévia
Esteviosídeo
Diabetes mellitus tipo 2
Glicosídeos.
description The aim of the present article was to search for scientific evidence to evaluate the function and action of stevioside in     patients with mellitus diabetes type 2. This work is an integrative literature review, the sources were linked in the following databases: (Scielo), (PubMed), LILACS and Academic Google. It was chosen some selection for the present sample and criteria for original articles indexed from 2017 to 2021 were established. The choice of this period presented results to the criterion of temporality, in which the five-year selected period was considered, as these are more current publications, in English and Portuguese in the studies analyzed, it was evidenced that stevioside is a glycosidic compound with high sweetness, low caloric value, including the interaction with glimeripedine and metformin, which enhances glycemic reduction through antioxidant actions and improves the lipid profile. It highlighted the action in reducing glucose and total cholesterol levels, preventing oxidative damage and improving liver and kidney function, as well as reducing damage to internal organs through removing tissue collagen and contributing to normal cardiac functioning. It also demonstrates positive results in satiety, contributing to a delay in gastric emptying and being useful in the treatment of obesity, working in the inhibition of glucose absorption. According this database, it is concluded that stevioside has preventive and metabolic function, besides to promote pre-clinical and experimental studies, culminating in non-caloric, anti-diabetic and anti-hyperglycemic effects, with sensory, therapeutic and nutritional quality.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22051
10.33448/rsd-v10i14.22051
url https://rsdjournal.org/index.php/rsd/article/view/22051
identifier_str_mv 10.33448/rsd-v10i14.22051
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22051/19732
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 14; e331101422051
Research, Society and Development; Vol. 10 Núm. 14; e331101422051
Research, Society and Development; v. 10 n. 14; e331101422051
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052790267183104